Daiichi Sankyo

Activities: Packaging Research & Development Pharmaceutical

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
  3. ISPE announces 2024 Facility of the Year Awards category winners The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
  4. Tabletability, compactability and compressibility: What’s the difference? To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
  5. Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Therapeutic: datopotamab deruxtecan for breast cancer

Of all the various forms of breast cancer, triple negative is the most aggressive subtype
Research & Development

AstraZeneca and Daiichi Sankyo reveal phase 3 lung cancer study

Results for the TROP2-directed antibody drug conjugate demonstrated statistically significant improvement in progression-free survival vs. standard chemotherapy
Drug Delivery

ProLynx collaborates with Daiichi Sankyo on drug delivery

The collaboration will evaluate the utility of the releasable linker technology in half-life extension of small-molecule drugs after intravitreal injection
Finance

Heptares Therapeutics enters agreement with Daichi Sankyo

The collaboration aims to discover and develop novel, small-molecules for the treatment of pain
Pharmaceutical

Amgen and Daiichi Sankyo to commercialise biosimilars in Japan

The exclusive agreement includes nine biosimilars in late-stage development
Drug Delivery

Nitto Denko enters drug delivery partnership with Daiichi Sankyo

To accelerate the commercialisation of Nitto’s PassPort transdermal drug delivery technology
Research & Development

Daiichi Sankyo appoints Antoine Yver as Global Head, Oncology Research and Development

He will lead all global R&D across the oncology therapeutic area
Subscribe now